Trading ideas: Duopharma, DNeX, Dayang, Varia, Kee Ming


KUALA LUMPUR: Duopharma Biotech Bhd, Dagang Nexchange Bhd (DNeX), Dayang Enterprise Holdings Bhd, Varia Bhd and Kee Ming Holdings Bhd are among the stocks to watch today following their latest news.

Duopharma has secured a three-year RM155.3mil contract from the Health Ministry to supply recombinant human insulin products and reusable insulin pens to government healthcare facilities nationwide, providing a positive earnings contribution through June 2029.

DNeX has acquired a 20% stake in TI Exploration & Production Sdn Bhd to strengthen its energy portfolio and expand its presence in Terengganu and the regional energy sector.

Dayang has entered into a 50:50 joint venture with Brunei-based Petrokon Utama Sdn Bhd (PUSB) to pursue maintenance, turnaround and construction opportunities in Brunei's oil and gas sector, supporting its strategy to expand its regional footprint and strengthen its presence in the country's energy industry.

Varia, through its indirect wholly owned subsidiary Varia Southrise Sdn Bhd, has partnered Seri Alam Properties Sdn Bhd to develop a RM250mil medium-cost residential project in Bandar Seri Alam, Johor Bahru, comprising 645 apartment units across two high-rise blocks.

Kee Ming has secured a RM21.36mil subcontract to undertake electrical engineering works for a hyperscale data centre project in Puncak Alam, boosting its order book and earnings visibility through end-2026.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Duopharma , DNeX , Dayang Enterprise , Varia , Kee Ming

Next In Business News

Ralph Lauren sells a dream
FMCG market charts new growth path
ETFs: Tip of the leverage iceberg
Health at a premium
Hailstorm over rides
Steering through regulatory waters
Clearer skies for S-REITs
From college pals to billionaires
Cracks emerge in private credit
A time to stay selective

Others Also Read